Nektar Therapeutics (NKTR) Interest Coverage Ratio (2010 - 2020)
Nektar Therapeutics (NKTR) recorded quarterly Interest Coverage Ratio of 120.11 in Q2 2020, down 457.61% quarter-over-quarter from 21.54 in Q1 2020, and down 466.17% on a YoY basis from 32.8 in Q3 2019.
Nektar Therapeutics (NKTR) Interest Coverage Ratio (2010 - 2020) Analysis & Trends
Nektar Therapeutics' Interest Coverage Ratio history runs 11 years deep, the most recent figure standing at 120.11 for Q2 2020.
- In Q2 2020, Interest Coverage Ratio fell 466.17% year-over-year to 120.11; the TTM figure through Mar 2021 stood at 619.59 (down 2948.56% YoY), while the FY2020 annual figure was 62.05, down 200.5% from the prior year.
- Interest Coverage Ratio was 120.11 for Q2 2020 at Nektar Therapeutics, down from 21.54 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 180.8 in Q2 2018 to a low of 120.11 in Q2 2020.
- Historically, Interest Coverage Ratio has averaged 7.09 across 5 years, with a median of 13.16 in 2017.
- The sharpest annual moves came in 2016 and 2018: Interest Coverage Ratio sank 5977.31% in 2016, then soared 2066.6% in 2018.
- A 5-year view of Interest Coverage Ratio shows it stood at 5.79 in 2016, then increased by 26.33% to 4.27 in 2017, then sank by 334.1% to 18.52 in 2018, then retreated by 9.05% to 20.2 in 2019, then tumbled by 494.63% to 120.11 in 2020.
- The last three Interest Coverage Ratio figures came in at 120.11 (Q2 2020), 21.54 (Q1 2020), and 20.2 (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Nektar Therapeutics | 1.51 Bn | 939.55 Mn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -120.11 |
| Mar 31, 2020 | -21.54 |
| Dec 31, 2019 | -20.20 |
| Sep 30, 2019 | -18.20 |
| Jun 30, 2019 | -21.21 |
| Mar 31, 2019 | -23.09 |
| Dec 31, 2018 | -18.52 |
| Sep 30, 2018 | -18.12 |
| Jun 30, 2018 | 180.80 |
| Mar 31, 2018 | -16.24 |
| Dec 31, 2017 | -4.27 |
| Sep 30, 2017 | 12.54 |
| Jun 30, 2017 | -9.19 |
| Mar 31, 2017 | -10.08 |
| Dec 31, 2016 | -5.79 |
| Sep 30, 2016 | -5.86 |
| Jun 30, 2016 | -6.81 |
| Mar 31, 2016 | -1.67 |
| Dec 31, 2015 | -5.07 |
| Sep 30, 2015 | 0.10 |